427 related articles for article (PubMed ID: 15662001)
41. Central actions of adipocyte hormones.
Ahima RS
Trends Endocrinol Metab; 2005 Sep; 16(7):307-13. PubMed ID: 16098759
[TBL] [Abstract][Full Text] [Related]
42. Obesity: the two faces of fat.
Powell K
Nature; 2007 May; 447(7144):525-7. PubMed ID: 17538594
[No Abstract] [Full Text] [Related]
43. Obesity-induced inflammation: a metabolic dialogue in the language of inflammation.
Ferrante AW
J Intern Med; 2007 Oct; 262(4):408-14. PubMed ID: 17875176
[TBL] [Abstract][Full Text] [Related]
44. Human adipose tissue macrophages are of an anti-inflammatory phenotype but capable of excessive pro-inflammatory mediator production.
Zeyda M; Farmer D; Todoric J; Aszmann O; Speiser M; Györi G; Zlabinger GJ; Stulnig TM
Int J Obes (Lond); 2007 Sep; 31(9):1420-8. PubMed ID: 17593905
[TBL] [Abstract][Full Text] [Related]
45. From chronic overnutrition to insulin resistance: the role of fat-storing capacity and inflammation.
Lionetti L; Mollica MP; Lombardi A; Cavaliere G; Gifuni G; Barletta A
Nutr Metab Cardiovasc Dis; 2009 Feb; 19(2):146-52. PubMed ID: 19171470
[TBL] [Abstract][Full Text] [Related]
46. Fat in all the wrong places.
Friedman J
Nature; 2002 Jan; 415(6869):268-9. PubMed ID: 11796987
[No Abstract] [Full Text] [Related]
47. [Clinical significance of leptin].
Joost HG; Becker W
Dtsch Med Wochenschr; 2000 Jun; 125(23):746-8. PubMed ID: 10902510
[No Abstract] [Full Text] [Related]
48. [Tightening the belt! "Spare tires" promote insulin resistance].
MMW Fortschr Med; 2004 Aug; 146(33-34):51. PubMed ID: 15526633
[No Abstract] [Full Text] [Related]
49. [Role of brown and perivascular adipose tissue in vascular complications due to obesity].
Gómez-Hernández A; Perdomo L; Escribano Ó; Benito M
Clin Investig Arterioscler; 2013; 25(1):36-44. PubMed ID: 23522280
[TBL] [Abstract][Full Text] [Related]
50. Evolutionary perspectives on the obesity epidemic: adaptive, maladaptive, and neutral viewpoints.
Speakman JR
Annu Rev Nutr; 2013; 33():289-317. PubMed ID: 23862645
[TBL] [Abstract][Full Text] [Related]
51. Cellular mechanisms of insulin action: implications for insulin resistance and type II diabetes mellitus.
Pershadsingh HA; Christensen RL; McDonald JM
Clin Chem; 1986 Oct; 32(10 Suppl):B19-27. PubMed ID: 3530537
[No Abstract] [Full Text] [Related]
52. Genetic and environmental interactions in obesity and type 2 diabetes.
Romao I; Roth J
J Am Diet Assoc; 2008 Apr; 108(4 Suppl 1):S24-8. PubMed ID: 18358250
[TBL] [Abstract][Full Text] [Related]
53. All obesity is not created equal.
Rosch PJ
Science; 2003 Sep; 301(5638):1325. PubMed ID: 12958343
[No Abstract] [Full Text] [Related]
54. Physical Inactivity, Obesity, and Type 2 Diabetes: An Evolutionary Perspective.
Eaton SB; Eaton SB
Res Q Exerc Sport; 2017 Mar; 88(1):1-8. PubMed ID: 28129048
[TBL] [Abstract][Full Text] [Related]
55. Obesity with insulin resistance: experimental insights.
Clark MG; Rattigan S; Clark DG
Lancet; 1983 Nov; 2(8361):1236-40. PubMed ID: 6139579
[No Abstract] [Full Text] [Related]
56. A modest proposal to meet our Kyoto commitments: the answer lies within.
Katzmarzyk PT
CMAJ; 2003 Dec; 169(12):1293. PubMed ID: 14662668
[No Abstract] [Full Text] [Related]
57. Obesity and insulin resistance.
Kahn BB; Flier JS
J Clin Invest; 2000 Aug; 106(4):473-81. PubMed ID: 10953022
[No Abstract] [Full Text] [Related]
58. Focus issue: diabetes--fighting fat on multiple fronts.
Adler EM
Sci STKE; 2005 Jan; 2005(268):eg2. PubMed ID: 15671478
[TBL] [Abstract][Full Text] [Related]
59. A burning question: does an adipokine-induced activation of the immune system mediate the effect of overnutrition on type 2 diabetes?
Tataranni PA; Ortega E
Diabetes; 2005 Apr; 54(4):917-27. PubMed ID: 15793228
[TBL] [Abstract][Full Text] [Related]
60. The evil axis of obesity, inflammation and type-2 diabetes.
Das A; Mukhopadhyay S
Endocr Metab Immune Disord Drug Targets; 2011 Mar; 11(1):23-31. PubMed ID: 21348821
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
